Pathologic findings from the national surgical adjuvant breast project (NSABP) eight-year update of protocol b-17: Intraductal carcinoma

Cancer

Volumn 86, Issue 3, 1999, Pages 429-438

  Fisher, Edwin R ^a,b   Dignam, James ^a   Tan Chiu, Elizabeth ^a   Costantino, Joseph ^a   Fisher, Bernard ^a   Paik, Soonmyung ^a   Wolmark, Norman ^a  

^a NSABP Foundation Inc   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Breast; Ductal carcinoma in situ; Intraductal carcinoma; Pathology; Treatment

Indexed keywords

ADJUVANT CHEMOTHERAPY; ARTICLE; BREAST CANCER; CLINICAL PROTOCOL; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; NECROSIS; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY, SEGMENTAL; NECROSIS; NEOPLASM INVASIVENESS; NEOPLASM, RESIDUAL; NEOPLASMS, SECOND PRIMARY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES;

EID: 0033178304     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO;2-Y     Document Type: Article

References (39)

1. Fisher B, Costantino J, Redmond C, Fisher ER, Margolese R, Dimitrov N, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993;328:1581-6.
2. Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, et al. Lumpectomy and radiation therapy: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998;16:441-52.
3. Fisher ER, Costantino J, Fisher B, Palekar AS, Redmond C, Mamounas E. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17: intraductal carcinoma (ductal carcinoma in situ). Cancer 1995; 75:1310-9.
4. Marks LB, Prosnitz LR. Lumpectomy with and without radiation for early-stage breast cancer and DCIS. Oncology 1997;11:1361-74.
5. Fisher ER, Sass R, Fisher B, Wickerham L, Paik SM. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 6). II. Intraductal carcinoma (DCIS). Cancer 1986;57:197-208.
6. Fisher ER, Leeming R, Anderson S, Redmond C, Fisher B. Conservative management of intraductal carcinoma (DCIS) of the breast. J Surg Oncol 1991;47:139-47.
7. Fisher ER. Pathological considerations relating to the treatment of intraductal carcinoma (ductal carcinma in situ) of the breast. CA Cancer J Clin 1997;47:52-64.
8. Fisher ER. Ductal carcinoma in situ: the National Surgical Adjuvant Breast Project (NSABP) experience. In: Silverstein MJ, editor. Ductal carcinoma in situ: a diagnostic and therapeutic dilemma. Baltimore: Williams and Wilkins, 1997: 259-69.
9. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
10. Rosner B. Fundamentals of biostatistics. 4th edition. Belmont, CA: Duxbury Press, 1995:585-94.
11. Cox DR. Regression models and life tables. J R Stat Soc B 1972;34:187-220.
12. Prentice RL, Kalbfleisch JD, Peterson AV, Flournoy N, Fareweell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics 1978;34:541-54.
13. Gaynor JJ, Feuer EJ, Tan CC, Wu DH, Little CR, Straus DJ, et al. On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J Am Stat Assoc 1993;88:400-9.
14. Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ER. Prognostic classification of breast ductal carcinoma in situ. Lancet 1995;345:1154-7.
15. Silverstein MJ, Lagios MD, Craig PH, Waisman JR, Lewinsky BS, Colburn WJ. A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996;77:2267-74.
16. Lagios MD. Duct carcinoma in situ: biological implications for clinical practice. Semin Oncol 1996;23(Suppl 2):6-11.
17. Bobrow LG, Millis RR. The pathology of ductal carcinoma in situ of the breast. Clin Oncol 1995;17:232-5.
18. Lagios MD. Duct carcinoma in situ: pathology and treatment. Surg Clin North Am 1990;70:853-71.
19. Ottesen GL, Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA. Ductal carcinoma in situ of the female breast: short-term results of a prospective nationwide study. Am J Surg Pathol 1992;16:1183-96.
20. Bellamy COC, McDonald C, Salter DM, Chetty U, Anderson TJ. Non-invasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum Pathol 1993;24:16-23.
21. Holland R, Peterse JL, Mills RR, Eusebi V, Faverly D, van de Vijer MJ, et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 1994;11:167-80.
22. Lennington WJ, Jensen RA, Dalton LW, Page DL. Ductal carcinoma in situ of the breast: heterogeneity of individual lesions. Cancer 1994;73:118-24.
23. Bobrow LG, Happerfield LC, Gregory WM. The classification of ductal carcinoma in situ and its association with biological markers. Semin Diagn Pathol 1994;11:199-207.
24. Consensus Conference on the Classification of Ductal Carcinoma in Situ. Cancer 1997;80:1798-1802.
25. Fisher ER. Lumpectomy margins and much more [editorial]. Cancer 1997;79:1453-8.
26. Cheng L, Al-Kaisi N, Gordon NH, Liu AY, Gebrail F, Shenk RP. Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease. J Natl Cancer Inst 1997;89:1356-60.
27. Silverstein MJ. Predicting residual disease and local recurrence in patients with ductal carcinoma in situ [editorial]. J Natl Cancer Inst 1997;89:1330-1.
28. Aarnesson LG, Smeds S, Fagerberg G, Gröntoft O. Follow-up of two treatment modalities for ductal cancer in situ of the breast. Br J Surg 1989;76:672-5.
29. Lagios MD. Lagios experience. In: Silverstein MJ, editor. Ductal carcinoma in situ, a diagnostic and therapeutic dilemma. Baltimore: Williams and Wilkins, 1997:361.
30. Sibbing DM, Blamey R. Nottingham experience. In: Silverstein, MJ, editor. Ductal carcinoma in situ: a diagnostic and therapeutic dilemma. Baltimore: Williams and Wilkins, 1997:367.
31. Faverley DRG, Burgers L, Buit P, Holland R. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 1994;11:193-8.
32. Fisher ER, Sass R, Fisher B, Gregorio R, Brown R, Wickerham L. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer 1986;57:1717-24.
33. Silverstein MJ, Gierson ED, Colburn WJ, Cope IM, Furmanski M, Genofsky GM, et al. Can intraductal breast carcinoma be excised completely by local excision? Clinical and pathologic predictors. Cancer 1994;73:2985-9.
34. Solin LJ, Yeh I, Kurtz J, Fourquet A, Recht A, Kuske R, et al. Ductal carcinoma in situ (intraductal carcinoma of the breast) treated with breast conservation surgery and definitive irradiation. Cancer 1993;71:2532-42.
35. Fisher ER, Sass R, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4). X. Discriminants for tenth year treatment failure. Cancer 1984;53:712-23.
36. Fisher ER, Siderits R. Value of cytometric analysis for distinction of intraductal carcinoma of the breast. Breast Cancer Res Treat 1992;21:165-72.
37. Zafrani B, Leroyer A, Bourquet A, Laurent M, Trophilme D, Validire P, et al. Mammographically detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erb B-2 proteins, and proliferative activity. Semin Diagn Pathol 1994;11: 208-14.
38. Guidi AJ, Fischer L, Haris JR, Schnitt SJ. Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst 1994;86:614-9.
39. Yassin R, Heffelfinger S, Miller, Fenoglio-Preiser C. Angiogenesis of in situ ductal carcinoma and proliferative ductal lesions of the breast [abstract]. Am J Clin Pathol 1994; 102:529.